6:55 PM
 | 
Feb 03, 2015
 |  BC Extra  |  Financial News

Insiders back Lysosomal in $20M A round

Lysosomal Therapeutics Inc. (Cambridge, Mass.) raised $20 million in a series A round from existing investors including Atlas Venture; Hatteras Venture Partners; Lilly Ventures; Sanofi-Genzyme BioVentures; Roche...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >